Cargando…
CD26 Inhibition Potentiates the Therapeutic Effects of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
Mesenchymal stem cells (MSCs) are recognized as potential treatments for multiple degenerative and inflammatory disorders as a number of animal and human studies have indicated their therapeutic effects. There are also several clinically approved medicinal products that are manufactured using these...
Autores principales: | Kim, Miyeon, Go, Jinyoung, Kwon, Ji Hye, Jin, Hye Jin, Bae, Yun Kyung, Kim, Eun-Young, Chang, Eun-Ju, Choi, Soo Jin, Kim, Seong Who |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846329/ https://www.ncbi.nlm.nih.gov/pubmed/35178399 http://dx.doi.org/10.3389/fcell.2021.803645 |
Ejemplares similares
-
Positively Correlated CD47 Activation and Autophagy in Umbilical Cord Blood-Derived Mesenchymal Stem Cells during Senescence
por: Kim, Gee-Hye, et al.
Publicado: (2021) -
Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy
por: Jin, Hye Jin, et al.
Publicado: (2013) -
The Upregulation of Toll-Like Receptor 3 via Autocrine IFN-β Signaling Drives the Senescence of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Through JAK1
por: Lee, Hyang Ju, et al.
Publicado: (2019) -
Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling
por: Kwon, Ji Hye, et al.
Publicado: (2021) -
A Small-Sized Population of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Shows High Stemness Properties and Therapeutic Benefit
por: Kim, Miyeon, et al.
Publicado: (2020)